Barclays Maintains Overweight on Sempra, Lowers Price Target to $90
Barclays analyst Nicholas Campanella maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $103 to $90.
Stocks · News reference
Truist Securities Maintains Buy on Sempra, Lowers Price Target to $94
Truist Securities analyst Richard Sunderland maintains Sempra (NYSE:SRE) with a Buy and lowers the price target from $96 to $94.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
JP Morgan Maintains Overweight on Sempra, Lowers Price Target to $99
JP Morgan analyst Aidan Kelly maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $102 to $99.
Scotiabank Initiates Coverage On Sempra with Sector Perform Rating, Announces Price Target of $83